⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5807559 | 1.00 | — | — | |
| SCHEMBL1824346 | 1.00 | — | — | |
| SCHEMBL3492014 | 1.00 | — | — | |
| SCHEMBL3492010 | 1.00 | — | — | |
| SCHEMBL22160590 | 0.81 | GABRR1 (0.43) | — | |
| SCHEMBL6335676 | 0.81 | GABRR1 (0.43) | — | |
| SCHEMBL4445650 | 0.81 | GABRR1 (0.43) | — | |
| SCHEMBL2811192 | 0.81 | GABRR1 (0.43) | — | |
| SCHEMBL13221050 | 0.81 | GABRR1 (0.43) | — | |
| SCHEMBL17340414 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10799605-B2 | Conjugate comprising a neurotensin receptor ligand and use thereof | 3B PHARMACEUTICALS GMBH (DE) | 2020-10-13 | — | — | US | disclosed |
| US-20170119913-A1 | CONJUGATE COMPRISING A NEUROTENSIN RECEPTOR LIGAND AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2017-05-04 | — | — | US | disclosed |
| US-20170119913-A1 | CONJUGATE COMPRISING A NEUROTENSIN RECEPTOR LIGAND AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2017-05-04 | — | — | US | disclosed |
| WO-2015188934-A1 | CONJUGATE COMPRISING A NEUROTENSIN RECEPTOR LIGAND AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2015-12-17 | — | — | WO | disclosed |
| US-6683154-B1 | UNNATURAL CATIONIC OLIGOMERS THAT HAVE NO KNOWN NATURAL COUNTERPART AND THAT DISPLAY ANTIBIOTIC ACTIVITY COMPARABLE TO THAT OF MAGAININ DERIVATIVE AGAINST AT LEAST FOUR DIFFERENT BACTERIAL SPECIES, YET EXHIBIT LOWER HEMOLYTIC ACTIVITY | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2004-01-27 | — | — | US | disclosed |